Hybridize Therapeutics
Netherlands - Oegstgeest
BiotechnologyFocus: RNA treatments for kidney disease
Hybridize Therapeutics is a life sciences company focused on RNA treatments for kidney disease.
Gene TherapyNephrology
Funding Stage
PUBLIC
Employees
1-50
Total Funding
$300M
Open Jobs
0
Open Jobs (0)
No open positions listed yet. Check their careers page directly.